Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
To Evaluate the safety and tolerability after KD101 single oral dosing in healthy male
subjects
To Evaluate the pharmacokinetic property after KD101 single oral dosing in healthy male
subjects
To Evaluate the effect of food on bioavailability after KD101 single oral dosing in healthy
male subjects